Respective Roles of CYP2A5 and CYP2F2 in the Bioactivation of 3-Methylindole in Mouse Olfactory Mucosa and Lung: Studies Using Cyp2a5-Null and Cyp2f2-Null Mouse Models

被引:13
|
作者
Zhou, Xin [1 ,2 ]
D'Agostino, Jaime [1 ,2 ]
Li, Lei [1 ,2 ]
Moore, Chad D. [3 ]
Yost, Garold S. [3 ]
Ding, Xinxin [1 ,2 ]
机构
[1] New York State Dept Hlth, Wadsworth Ctr, Mol Toxicol Lab, Albany, NY 12201 USA
[2] SUNY Albany, Sch Publ Hlth, Albany, NY USA
[3] Univ Utah, Dept Pharmacol & Toxicol, Salt Lake City, UT 84112 USA
基金
美国国家卫生研究院;
关键词
METABOLIC-ACTIVATION; DEHYDROGENATION; TOXICITY; 2,6-DICHLOROBENZONITRILE; BRONCHIOLAR; NAPHTHALENE; MECHANISMS; EXPRESSION; NECROSIS;
D O I
10.1124/dmd.111.044081
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this study was to determine whether mouse CYP2A5 and CYP2F2 play critical roles in the bioactivation of 3-methylindole (3MI), a tissue-selective toxicant, in the target tissues, the nasal olfactory mucosa (OM) and lung. Five metabolites of 3MI were identified in NADPH- and GSH-fortified microsomal reactions, including 3-glutathionyl-S-methylindole (GS-A1), 3-methyl-2-glutathionyl-S-indole (GS-A2), 3-hydroxy-3-methyleneindolenine (HMI), indole-3-carbinol (I-3-C), and 3-methyloxindole (MOI). The metabolite profiles and enzyme kinetics of the reactions were compared between OM and lung, and among wild-type, Cyp2a5-null, and Cyp2f2-null mice. In lung reactions, GS-A1, GS-A2, and HMI were detected as major products, and I-3-C and MOI, as minor metabolites. In OM reactions, all five metabolites were detected in ample amounts. The loss of CYP2F2 affected formation of all 3MI metabolites in the lung and formation of HMI, GS-A1, and GS-A2 in the OM. In contrast, loss of CYP2A5 did not affect formation of 3MI metabolites in the lung but caused substantial decreases in I-3-C and MOI formation in the OM. Thus, whereas CYP2F2 plays a critical role in the 3MI metabolism in the lung, both CYP2A5 and CYP2F2 play important roles in 3MI metabolism in the OM. Furthermore, the fate of the reactive metabolites produced by the two enzymes through common dehydrogenation and epoxidation pathways seemed to differ with CYP2A5 supporting direct conversion to stable metabolites and CYP2F2 supporting further formation of reactive iminium ions. These results provide the basis for understanding the respective roles of CYP2A5 and CYP2F2 in 3MI's toxicity in the respiratory tract.
引用
收藏
页码:642 / 647
页数:6
相关论文
共 50 条
  • [1] Generation and Characterization of a Cyp2f2-Null Mouse and Studies on the Role of CYP2F2 in Naphthalene-Induced Toxicity in the Lung and Nasal Olfactory Mucosa
    Li, Lei
    Wei, Yuan
    Van Winkle, Laura
    Zhang, Qing-Yu
    Zhou, Xin
    Hu, Jinping
    Xie, Fang
    Kluetzman, Kerri
    Ding, Xinxin
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 339 (01): : 62 - 71
  • [2] Role of CYP2A5 in the Clearance of Nicotine and Cotinine: Insights from Studies on a Cyp2a5-null Mouse Model
    Zhou, Xin
    Zhuo, Xiaoliang
    Xie, Fang
    Kluetzman, Kerri
    Shu, Yue-Zhong
    Humphreys, W. Griffith
    Ding, Xinxin
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 332 (02): : 578 - 587
  • [3] Role of CYP2A5 in the metabolism of nicotine and cotinine: insights from a Cyp2a5-null mouse model and a CYP2A6-humanized mouse model
    Zhou, Xin
    Zhuo, Xiaoliang
    Xie, Fang
    Kluetzman, Kerri
    Shu, Yue-Zhong
    Humphreys, William
    Ding, Xinxin
    DRUG METABOLISM REVIEWS, 2009, 41 : 27 - 28
  • [4] Role of CYP2A5 and 2G1 in acetaminophen metabolism and toxicity in the olfactory mucosa of the Cyp1a2(-/-) mouse
    Genter, MB
    Liang, HC
    Gu, J
    Ding, XX
    Negishi, M
    McKinnon, RA
    Nebert, DW
    BIOCHEMICAL PHARMACOLOGY, 1998, 55 (11) : 1819 - 1826
  • [5] Bioactivation of 1,1-dichloroethylene by CYP2E1 and CYP2F2 in murine lung
    Simmonds, AC
    Ghanayem, BI
    Sharma, A
    Reilly, CA
    Millen, B
    Yost, GS
    Forkert, PG
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 310 (03): : 855 - 864
  • [6] Differential xenobiotic induction of CYP2A5 in mouse liver, kidney, lung, and olfactory mucosa
    Su, T
    He, WL
    Gu, J
    Lipinskas, TW
    Ding, XX
    DRUG METABOLISM AND DISPOSITION, 1998, 26 (08) : 822 - 824
  • [7] Role of human CYP2A13 and CYP2F1 in naphthalene bioactivation and toxicity in the lung and nasal mucosa of a CYP2A13/2F1-humanized Mouse
    Li, Lei
    Jia, Kunzhi
    Hartog, Matthew
    Wang, Yanan
    Van Winkle, Laura
    Ding, Xinxin
    FASEB JOURNAL, 2014, 28 (01):
  • [8] The activities of Cyp1a1 and Cyp2a5 in mouse brain
    Ozdamar, E. D.
    Iscan, M.
    Eke, B. C.
    TOXICOLOGY LETTERS, 2005, 158 : S208 - S208
  • [9] ROLE OF CYP2ABFGS IN NNK BIOACTIVATION AND LUNG TUMORIGENESIS: INSIGHTS FROM A NOVEL CYP2ABFGS-NULL MOUSE
    Li, Lei
    Megaraj, Vandana
    Wei, Yuan
    Ding, Xinxin
    DRUG METABOLISM REVIEWS, 2014, 45 : 57 - 58
  • [10] Characterization of a Cyp2a(4/5)bgs-null Mouse Model: Role of CYP2A and CYP2B in Nicotine Metabolism
    Li, Lei
    Wei, Yuan
    Zhou, Xin
    Hough, Lindsay B.
    Ding, Xinxin
    FASEB JOURNAL, 2012, 26